Skip to content

HORIZONH2020FP7

Fundacion Para la Investigacion de Malaga en Biomedicina y Salud

Country
ESSpain
Defence projects
0
Projects, all programmes
13
As coordinator
10
EU contribution (CORDIS)
EUR 3,543,594
Active
2008 to 2025

Projects

13 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
CARABELA-NF1CARABELA-NF1: CDK4/6i Resistance and Biomarker Analysis in Neoadjuvant settings from CARABELA trial.HORIZON2025CoordinatorEUR 194,075
ClimAIrClimate change and air contamination: Artificial Intelligence applied on the correlation between air pollutants and non-communicable respiratory diseases in EuropeHORIZON2025Third partyNot stated
MORBIUSCure for Miniature Brittle Bones: Treatment of Osteogenesis ImpeRfecta patient-derived Bone organoids with Innovative AAV-mediated Ultimate Gene-editing SystemHORIZON2025CoordinatorEUR 226,441
GRADIENTImpact of gut microbiota targeted dietary intervention on obesity: A precision medicine approachHORIZON2025CoordinatorEUR 181,153
ORACLEOptimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluationHORIZON2024CoordinatorEUR 1,405,894
PRE-BITUnderstanding the role of B cell phenotypes as a predictor of the efficacy and prognosis of allergen immunotherapy using allergic rhinitis to house dust mite as a modelHORIZON2023CoordinatorEUR 185,488
LIVERATIONUnravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence?HORIZON2023Third partyNot stated
halt-RONINDiscovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategiesHORIZON2022Third partyNot stated
ASSERTDevelopment of a nanotechnology-based innovative assay for the diagnosis of allergy to BetalactamsH20202021CoordinatorEUR 259,399
IMMUNOMARKOmics integration for precision cancer immunotherapyH20202018CoordinatorEUR 170,122
DIRECtATargeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destruction.H20202018CoordinatorEUR 158,122
DendrimmuneassaysDevelopment of sophisticated dendrimeric nanostructural materials with potential applications in drug allergy diagnosis: Towards immunoassays and cellular tests (basophil activation tests)FP72012CoordinatorEUR 168,896
REPROBESITYSearch for new therapeutic agents against complicated obesity by reprofiling existing drugsFP72008CoordinatorEUR 594,005

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.